Skip to main content
. Author manuscript; available in PMC: 2024 Dec 4.
Published in final edited form as: Lancet Neurol. 2024 Feb;23(2):168–177. doi: 10.1016/S1474-4422(23)00414-3

Table 1.

Demographical and clinical description of the full sample

Pooled estimate (mean/frequency) 95%CI Npatients Nsites I2

Demographics
Sex (% women) 60% [56, 64] 1092 36 35.0
Handedness (% right) 93% [90, 95] 872 32 42.8
Years of education 14.1 [13.9, 14.2] 949 35 93.1
APOE (% e4 carriers) 43% [35, 50] 451 22 55.5
Clinical
Age at symptom onset, years 59.4 [58.9, 59.8] 1031 34 77.4
Age at diagnosis, years 63.2 [62.8, 63.6] 1067 36 76.8
Age at death, years 70.5 [69.5, 71.4] 227 20 72.7
Diagnosis (% PCA pure) 80% [72, 89] 968 34 97.9
MMSE at diagnosis, points (range : 0–30) 20.7 [20.4, 21.1] 904 31 69.9
CDR at diagnosis (% CDR≥1) 62% [53, 71] 558 27 81.1
Mendez criteria (% fulfilled) 75% [60, 90] 535 21 99.4
Tang-Wai criteria (% fulfilled) 80% [68, 92] 535 21 98.6
Early disturbance of posterior function (% yes) 91% [85, 97] 992 36 98.1
Insidious onset and gradual progression (% yes) 99% [98, 99] 809 34 0

Mean values or frequency, and their corresponding 95% confidence intervals are derived from the meta-analysis of all available data. Sites with only one available datapoint (two sites for “MMSE”, one site for “age at death”) were not included in the meta-analysis. Raw data, including breakdown of each site, is presented in Supplementary Figures 110. Abbreviations: MMSE: Mini-Mental State Examination, CDR: Clinical Dementia Rating scale.